¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø - À¯Çüº°, Á¦Ç°º°, ±â¼úº°, ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±â´Éº°, ¼³Ä¡ À¯Çüº°, ¼Ö·ç¼Çº°(-2033³â)
Sleep Apnea Device Market Analysis and Forecast to 2033: Type, Product, Technology, Component, Application, End User, Functionality, Installation Type, Solutions
»óǰÄÚµå : 1632946
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 362 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,757,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 8,179,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,602,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀåÀº CAGR 5.8%¸¦ ¹Ý¿µÇÏ¿© 2023³â 75¾ï ´Þ·¯¿¡¼­ 2033³â¿¡´Â 129¾ï ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀåÀº ¼ö¸é Áß È£Èí Áß´ÜÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀÎ ¼ö¸é ¹«È£Èí ÁõÈıºÀ» Áø´Ü ¹× Ä¡·áÇÏ´Â ÀÇ·á±â±âÀÇ ¼³°è, Á¦Á¶, ÆÇ¸Å¿¡ ƯȭµÈ ¾÷°è¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â CPAP ÀåÄ¡, °æ±¸ ÀåÄ¡, ÀûÀÀÇü ¼­º¸ ȯ±â ÀåÄ¡, ¼ö¸é Æú¸®±×·¡ÇÁ °Ë»ç ¹× ÀçÅà ¼ö¸é °Ë»ç µîÀÇ Áø´Ü µµ±¸°¡ Æ÷ÇԵǾî Çõ½ÅÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ¼Ö·ç¼ÇÀ» ÅëÇØ Áõ°¡ÇÏ´Â ¼ö¸éÀå¾ÖÀÇ À¯º´·ü¿¡ ´ëóÇϰí ȯÀÚÀÇ Äɾ Çâ»ó½Ãŵ´Ï´Ù.

¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀåÀº ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ Àνİú À¯º´·ü Áõ°¡¿¡ °ßÀÎµÇ¾î °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. Æó»ö¼º ¼ö¸é ¹«È£Èí ÁõÈıºÀÇ Ä¡·á¿¡ È¿°úÀûÀ̱⠶§¹®¿¡ Áö¼ÓÀû ¾ç¾Ð È£Èí±â(CPAP) ÀåÄ¡°¡ ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ±¸°­ ±â±¸´Â ÆíÀǼº°ú ºñħ½À¼ºÀ¸·Î Àα⸦ ¾ò°í ÀÖÀ¸¸ç µÎ ¹øÂ°·Î ³ôÀº ½ÇÀûÀ» ¿Ã¸®°í ÀÖ´Â ÇÏÀ§ ºÎ¹®ÀÔ´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, °í±Þ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í ¼ö¸é ¹«È£Èí ÁõÈıºÀÇ ³ôÀº À¯º´·üÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. À¯·´ÀÌ ¾à°£ÀÇ Â÷ÀÌ·Î À̾îÁö°í, ÀÎÁöµµ Çâ»ó°ú À¯¸®ÇÑ »óȯ Á¤Ã¥¿¡ ÀÇÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ±¹°¡º°·Î, ¹Ì±¹Àº ±â¼úÀÇ Áøº¸¿Í ¼ö¸é °Ç°­¿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±Ù¿¡ °ßÀεǾî ÃÖ°íÀÔ´Ï´Ù. µ¶ÀÏÀº °­·ÂÇÑ °Ç°­ °ü¸® ½Ã½ºÅÛ°ú ¼ö¸é ¹«È£Èí ÁõÈıº Ä¡·á ÀåºñÀÇ µµÀÔ Áõ°¡¸¦ ¹Ý¿µÇÏ¿© µÎ ¹øÂ°·Î ³ôÀº ½ÇÀûÀ» ¿Ã¸®°í ÀÖ½À´Ï´Ù. ½ÃÀå È®´ë´Â Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ÁÖ¿ä ±â¾÷ °£ÀÇ Àü·«Àû Á¦ÈÞ¿¡ ÀÇÇØ ´õ¿í °­È­µÇ¾î ÀåºñÀÇ È¿´É°ú ȯÀÚ ÄÄÇöóÀ̾𽺰¡ Çâ»óµÇ¾ú½À´Ï´Ù.

2023³â ½ÃÀå ±Ô¸ð´Â 1,200¸¸ ´ë·Î ÃßÁ¤µÇ¸ç, 2033³â¿¡´Â 2,000¸¸ ´ë¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù. Áö¼ÓÀû ±âµµ¾ç¾Ð(CPAP) ÀåÄ¡°¡ 45%·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÑ ´ÙÀ½ ±¸°­±â±¸°¡ 30%, ÀûÀÀÇü ¼­º¸ ȯ±âÀåÄ¡°¡ 25%°¡ µÇ°í ÀÖ½À´Ï´Ù. CPAP ºÐ¾ß´Â ÀÔÁõµÈ È¿´É°ú ±â¼úÀÇ ¹ßÀüÀ¸·Î ³Î¸® äÅõǴ °ÍÀÌ ÀåÁ¡ÀÌ µÇ¾ú½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ResMed, Philips Respironics, Fisher & Paykel Healthcare¸¦ Æ÷ÇÔÇϸç, °¢°¢Àº Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ResMed´Â µðÁöÅÐ Çコ ¼Ö·ç¼Ç¿¡ ÁÖ·ÂÇϰí ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, Philips Respironics´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎÀÇ Çõ½Å¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

°æÀï ±¸µµ´Â Àû±ØÀûÀÎ ¿¬±¸°³¹ß ÅõÀÚ¿Í Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÀÇÇØ Çü¼ºµË´Ï´Ù. FDA Áöħ ¹× EU ÀÇ·á±â±â ±ÔÁ¦¿Í °°Àº ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©´Â ƯÈ÷ ÄÄÇöóÀ̾𽺠¹× Çõ½Å°ú °ü·ÃÇÏ¿© ½ÃÀå ¿ªÇп¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå Àü¸ÁÀº ½ÅÈï ½ÃÀå°ú ¿ø°Ý ÀÇ·á ÅëÇÕ¿¡ Å« ±âȸ°¡ ÀÖÀ¸¸ç ¿©ÀüÈ÷ À¯¸ÁÇÕ´Ï´Ù. »óȯ ¹®Á¦¿Í ´ëü ¿ä¹ý°úÀÇ °æÀï°ú °°Àº ¹®Á¦´Â ¿©ÀüÈ÷ ³²¾Æ ÀÖ½À´Ï´Ù. ±×·¯³ª AI¸¦ Ȱ¿ëÇÑ Áø´Ü°ú ȯÀÚ ¸ð´ÏÅ͸µÀÇ Áøº¸·Î »õ·Î¿î ¼ºÀå °¡´É¼ºÀÌ ¿­¸± °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀåÀº ºÏ¹Ì°¡ Áö¹èÀûÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº ¼ö¸é ¹«È£Èí ÁõÈıºÀÇ ³ôÀº À¯º´·ü°ú ÷´Ü °Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ¼ö¸éÀå¾Ö ¿¬±¸¿¡ »ó´çÇÑ ÅõÀÚ¸¦ ÇÏ°í ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ±â¾÷Àº È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ±â¼ú Çõ½ÅÀ» ½Ç½ÃÇß½À´Ï´Ù.

À¯·´Àº ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í °Ç°­ °ü¸® Á¤Ã¥ÀÇ µÞ¹ÞħÀ¸·Î ÀÎÇØ ¾à°£ÀÇ Â÷ÀÌ·Î °è¼ÓµÇ°í ÀÖ½À´Ï´Ù. ¿µ±¹°ú µ¶ÀÏÀÌ ÁÖ¿ä °øÇå±¹ÀÔ´Ï´Ù. ÀÌ ³ª¶óµéÀº Á¶±â Áø´Ü°ú Á¶±â Ä¡·á¸¦ Áß½ÃÇÏ¸ç ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ±â¼ú Áøº¸¿¡ ÁßÁ¡À» µÎ°í °æÀï·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ±Þ¼ºÀå °¡´É¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í µµ½ÃÈ­°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áß±¹°ú Àεµ´Â ¸Å¿ì Áß¿äÇÑ ½ÃÀåÀ¸·Î ÀÎÁöµµ¿Í °Ç°­ °ü¸®¿¡ ´ëÇÑ ¾×¼¼½º°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ ³ª¶ó¿¡¼­´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê°¡ Á¶±â Áø´Ü°ú Ä¡·á¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«´Â ¿Ï¸¸ÇÑ ¼ºÀåÀ» º¸¿©ÁÝ´Ï´Ù. °æÁ¦Àû °úÁ¦¿Í Á¦ÇÑµÈ ÀÇ·á ÀÎÇÁ¶ó°¡ ½ÃÀå °³Ã´ÀÇ Á¦¾àÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÎÁöµµ Çâ»ó°ú °Ç°­ °ü¸® ½Ã½ºÅÛÀÇ ¿Ï¸¸ÇÑ °³¼±Àº ¹Ì·¡ÀÇ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ºê¶óÁú°ú ³²¾ÆÇÁ¸®Ä«´Â ÁÖ¸ñÇÒ¸¸ÇÑ ½ÃÀåÀ¸·Î ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ºÀåÀÇ Â¡Á¶¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå¿¡ °üÇÑ Áß¿ä ÀλçÀÌÆ®

Á¦4Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå Àü¸Á

Á¦5Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå Àü·«

Á¦6Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå ±Ô¸ð

Á¦7Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : À¯Çüº°

Á¦8Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : Á¦Ç°º°

Á¦9Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ±â¼úº°

Á¦10Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦11Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ¿ëµµº°

Á¦12Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦13Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ±â´Éº°

Á¦14Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ¼³Ä¡ À¯Çüº°

Á¦15Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : ¼Ö·ç¼Çº°

Á¦16Àå ¼ö¸é ¹«È£ÈíÁõ ±â±â ½ÃÀå : Áö¿ªº°

Á¦17Àå °æÀï ±¸µµ

Á¦18Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global sleep apnea device market is anticipated to expand from $7.5 billion in 2023 to $12.9 billion by 2033, reflecting a CAGR of 5.8%.

The Sleep Apnea Device Market encompasses the industry dedicated to designing, manufacturing, and distributing medical devices that diagnose and treat sleep apnea, a disorder characterized by interrupted breathing during sleep. It includes CPAP machines, oral appliances, adaptive servo-ventilation devices, and diagnostic tools like polysomnography and home sleep tests, addressing the growing prevalence of sleep disorders and advancing patient care through innovative, user-friendly solutions.

The Sleep Apnea Device Market is witnessing robust growth, driven by increasing awareness and prevalence of sleep disorders. Continuous Positive Airway Pressure (CPAP) devices lead the market, owing to their effectiveness in treating obstructive sleep apnea. Oral appliances are the second-highest performing sub-segment, gaining popularity due to their convenience and non-invasive nature. In terms of regional performance, North America dominates the market, supported by advanced healthcare infrastructure and a high prevalence of sleep apnea. Europe follows closely, with significant growth attributed to rising awareness and favorable reimbursement policies. Within countries, the United States stands out as the top performer, driven by technological advancements and a proactive approach to sleep health. Germany emerges as the second-highest performing country, reflecting strong healthcare systems and increasing adoption of sleep apnea devices. The market's expansion is further bolstered by continuous innovation and strategic collaborations among key players, enhancing device efficacy and patient compliance.

In 2023, the market's volume was estimated at 12 million units, with expectations to reach 20 million units by 2033. Continuous Positive Airway Pressure (CPAP) devices command the largest market share at 45%, followed by oral appliances at 30%, and adaptive servo-ventilation devices at 25%. The CPAP segment benefits from its widespread adoption due to proven efficacy and technological advancements. Key players in this market include ResMed, Philips Respironics, and Fisher & Paykel Healthcare, each holding substantial shares. ResMed is noted for its focus on digital health solutions, while Philips Respironics emphasizes innovation in user-friendly designs.

The competitive landscape is shaped by aggressive R&D investments and strategic partnerships. Regulatory frameworks, such as the FDA's guidelines and the EU's Medical Device Regulation, significantly impact market dynamics, particularly regarding compliance and innovation. The outlook for the Sleep Apnea Device Market remains promising, with substantial opportunities in emerging markets and telemedicine integration. Challenges, including reimbursement issues and competition from alternative therapies, persist. However, advancements in AI-driven diagnostics and patient monitoring are expected to unlock new growth potential.

North America dominates the sleep apnea device market. The region benefits from a high prevalence of sleep apnea and advanced healthcare infrastructure. The United States leads with significant investments in sleep disorder research. Companies in the region are innovating to meet increasing demand for effective treatment options.

Europe follows closely, driven by rising awareness of sleep disorders and supportive healthcare policies. The United Kingdom and Germany are key contributors. These countries emphasize early diagnosis and treatment, fostering market growth. The region's focus on technological advancements enhances its competitive edge.

Asia Pacific exhibits rapid growth potential. Increasing disposable incomes and urbanization contribute to market expansion. China and India are pivotal markets, with growing awareness and healthcare accessibility. Government initiatives in these countries promote early diagnosis and treatment.

Latin America and the Middle East & Africa show moderate growth. Economic challenges and limited healthcare infrastructure constrain market development. However, increasing awareness and gradual improvements in healthcare systems offer future opportunities. Brazil and South Africa are noteworthy markets, showing signs of growth due to rising awareness.

Key Companies

Res Med, Fisher & Paykel Healthcare, De Vilbiss Healthcare, BMC Medical, Drive De Vilbiss Healthcare, Somnetics International, Apex Medical, 3 B Medical, Curative Medical, Compumedics, Lowenstein Medical, Transcend, Breas Medical, Air Avant Medical, Invacare Corporation, Circadiance, Somno Med, Oventus Medical, Vyaire Medical, Nox Medical

Sources

World Health Organization, Centers for Disease Control and Prevention, National Institutes of Health, American Sleep Apnea Association, European Respiratory Society, American Academy of Sleep Medicine, Sleep Research Society, European Sleep Research Society, National Sleep Foundation, World Sleep Society, International Classification of Sleep Disorders Conference, Sleep and Breathing Conference, World Sleep Congress, American Thoracic Society International Conference, European Lung Foundation, U.S. Food and Drug Administration, Health Canada, Australian Sleep Association, British Sleep Society, International Conference on Sleep Disorders and Medicine

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Sleep Apnea Device Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Sleep Apnea Device Market Outlook

5: Sleep Apnea Device Market Strategy

6: Sleep Apnea Device Market Size

7: Sleep Apnea Device Market, by Type

8: Sleep Apnea Device Market, by Product

9: Sleep Apnea Device Market, by Technology

10: Sleep Apnea Device Market, by Component

11: Sleep Apnea Device Market, by Application

12: Sleep Apnea Device Market, by End User

13: Sleep Apnea Device Market, by Functionality

14: Sleep Apnea Device Market, by Installation Type

15: Sleep Apnea Device Market, by Solutions

16: Sleep Apnea Device Market, by Region

17: Competitive Landscape

18: Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â